Pfizer Partners With Clear Creek Bio to Develop Oral COVID-19 Drug
Pfizer and Clear Creek Bio on Tuesday announced a collaboration to identify a potential drug candidate and develop a new class of oral treatment against COVID-19, as Pfizer seeks to expand its anti-infective pipeline.
Reuters Health Information
source https://www.medscape.com/viewarticle/985069?src=rss
Reuters Health Information
source https://www.medscape.com/viewarticle/985069?src=rss
Comments
Post a Comment